HealthEquity (HQY) Director Wellborn Exercises Options, Sells Shares

What Happened
Wellborn Gayle Furgurson, a director of HealthEquity, exercised 2,439 stock options (immediately exercisable) and acquired 2,439 shares at $47.21 per share (cost $115,145). The same 2,439 shares were sold in an open-market transaction at $90.00 per share for total proceeds of $219,510. The transactions together imply gross proceeds minus exercise cost of about $104,365 before fees and taxes. A separate line reporting the derivative disposition at $0 reflects the option conversion/exercise.

Key Details

• Transaction date: 2026-05-28
• Option exercise: 2,439 shares acquired at $47.21 = $115,145 (footnote F2: option immediately exercisable)
• Open-market sale: 2,439 shares sold at $90.00 = $219,510
• Net (proceeds minus exercise cost): ~ $104,365 (approximate, before commissions/taxes)
• Plan/authority notes: Transactions were effected under a Rule 10b5-1 trading plan adopted Jan 14, 2026 (F1). Power of attorney referenced in prior filing (per Remarks).
• Shares owned after the transaction: Not specified in the provided excerpt.
• Filing: Form 4 filed with accession on 2026-06-01 reporting the May 28, 2026 transactions.

Context
This is a common "exercise-and-sell" sequence: options were exercised and the resulting shares were promptly sold in the open market, so the event mainly realizes value rather than represents a new purchase signal. The reporting includes a derivative disposition line (reported at $0) that corresponds to conversion/exercise of the option. The 10b5-1 plan disclosure indicates the trades were executed according to a pre-established plan rather than ad hoc trading decisions.